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Background: Stent implantation into growing vessels is a common treatment option in infants and children with
congenital heart disease (CHD) and corresponding vessel lesions. After stent implantation in small children,
repetitive stent redilations are frequently necessary to accommodate for somatic growth. Until now, all available
stents have limited ﬁnal expansion diameters.
Material and results: The new Bentley BeGrow™ stent system for newborns and infants is a L605
cobalt‑chromium, pre-mounted, balloon expandable stent, which is compatible with a 4 French sheath and
0.014 inch guide wire thus allowing implantation in small vessels (4–6mm). It offers a new, unique stent design
that allows post-dilation steps up to Ø11.5mm.While re-dilating up toØ11.5mmthis new stentmaintains radial
force and shows uniform expansion with onlyminimal foreshortening. Predetermined breaking points allow the
stent struts to break in a controlled manner when exceeding a diameter of 11.5 mm. Residual radial force
maintains even after stent opening due to spiral arrangement of the predetermined breaking points. The
2 ﬁrst-in-man pulmonary artery stent implantations in a newborn with univentricular circulation and a toddler
with biventricular circulation are reported as part of the currently performed licencing trial (ClinicalTrials.gov
NCT03287024).
Conclusion: The low-proﬁle BeGrow™ stent system offers new treatment options for transcatheter stent implan-
tations in newborns and infants. In our ﬁrst experience, it can be effectively implanted. Longer follow-up
will evaluate multiple, stepwise redilations and controlled stent strut breakage, which have the potential to
accommodate for somatic vessel growth and/or subsequent implantation of larger stents.
© 2018 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Vascular stenosis in a growing vessel and a growing child (e.g. pul-
monary artery stenosis, aortic coarctation) is a frequent problem faced
in the treatment of children with congenital heart disease (CHD) [1].
Transcatheter stenting of these vessel stenosis principally is an attrac-
tive, minimal invasive treatment option [2]. Especially in small children
stents often have to be re-dilated and all have ﬁnal maximal expansion
diameters, which makes surgical explantation necessary during further
vessel growth [3,4]. This is especially true for stent implantations using
currently available, small, ﬂexible, low-proﬁle coronary stent systems in
newborns and infants, as these stents cannot be expanded beyond ap-
proximately 6–7 mm diameter [5].
The new Bentley BeGrow™ stent system for newborns and infants
offers a new, unique stent design that allows post-dilation steps up to
Ø11.5 mm to follow the growth of the vessel (see Fig. 1). While
redilating this stent, it maintains radial force and shows uniform expan-
sion with only minimal foreshortening before exceeding a diameter of
Ø11.5 mm. Furthermore, predetermined breaking points allow the
stent struts to break in a controlled and reliable manner when exceed-
ing a diameter of 11.5 mm. Residual radial force maintains even after
stent opening due to spiral arrangement of the predetermined breaking
points (see Fig. 1). First-in-man usage in children is reported here, while
results of ex-vivo bench testing and preclinical animal studies were
reported at recent conferences [6].
2. Material and results
We report the ﬁrst-in-man 2 cases of stent implantation into the pulmonary arteries
using the new Bentley BeGrow™ stent system for newborns and infants. Both reported
procedures were performed within the clinical licencing trial currently performed as
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prospective, multicentre study in central Europe (ClinicalTrials.gov NCT03287024). The
Bentley BeGrow™ stent system is a L605 cobalt‑chromium, pre-mounted, balloon
expandable stent. It is a low-proﬁle stent, which is compatible with a 4 French sheath and
0.014 inch guide wire. Currently available balloon diameter is 6 mm and stent lengths are
10, 13, 17, 20, and 24 mm. The stent is delivered on a low-proﬁle balloon with a balloon
catheter length of 100 cm. The nominal balloon pressure is 8 atm (800 kPa) and the rated
burst pressure of the balloon is 14 atm (1400 kPa). Predetermined breaking points of the
stent allow the stent struts to break in a controlled and reliable manner when exceeding a
stent diameter of 11.5 mm.
2.1. Case 1
This newborn baby underwent surgical Norwood I procedure for hypoplastic left
heart disease (mitral- and aortic atresia) with Damus-Kaye-Stansel anastomosis, aortic
arch reconstruction, ligation of the PDA and right sided modiﬁed Blalock-Taussig-Shunt
(mBTS, 3.5 mm) to palliate univentricular circulation on day 3 of life. Postoperatively
the baby remained ventilator dependent and echocardiography showed a stenosis at
the origin of the left pulmonary artery (LPA). Cardiac catheterization and angiography
2 days after surgery (patient weight at procedure 3.2 kg) conﬁrmed LPA origin stenosis,
Fig. 1.The low-proﬁle, 4 French compatible Bentley BeGrow™ stent system for newborns and infantswith its unique stent design and predetermined stent strut breakage points (top row).
Multiple stepwise redilations of the stent showing stent expansion and stent strut breakage with maintenance of radial force even after stent opening, due to spiral arrangement of
predetermined stent strut breaking points (lower row).
Fig. 2.A+B) Echocardiography and angiography showing severe right pulmonary artery (RPA) stenosis. C+D) Advancement of a 4 French Cook Flexor sheath to guide stent positioning.
E) Stent implantation of the BeGrow™ stent system into the right pulmonary artery. F) Postinterventional angiography showing successful stent expansion of the RPA and regular contrast
ﬂow to both PAs on angiography.
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with a minimal diameter at the site of stenosis of 1.9 mm. Distal LPA diameter
was maximal 3.5 mm, with the right pulmonary artery (RPA) centrally measuring
4.4 mm. A retrograde arterial approach via the mBTS was used to place a 0.014 inch
guidewire distally into the left lower lobe PA. The stent system was guided into its
position using a Cook Flexor 4 Fr long sheath. Stent positioning and implantation
were successful, opening the stent balloon using a maximum of 4 atm, generating a
ﬁnal stent diameter of 5.3 mm, which is the minimal stent diameter achievable with
the currently available 6 mm stent diameter. Postinterventional angiography conﬁrmed
successful stent expansion of the LPA and equal distribution of contrast ﬂow to both
PAs on angiography.
2.2. Case 2
This patient was born small for gestation age with a birth weight of 1.8 kg and a large
perimembranous malalignment ventricular septal defect (VSD) and coarctation of the
aorta and hypoplasia of the transverse aortic arch. The baby underwent surgery with
extended resection of the aortic coarctation, patch augmentation of the transverse aortic
arch and pulmonary artery banding (PA-banding) in the newborn period. At the age of
3 months the baby underwent surgical PA-debanding and VSD closure. Postoperatively
echocardiography showed severe RPA stenosis (Fig. 2 A). Angiography conﬁrmedRPA ste-
nosiswith aminimal diameter of 1.5mm(Fig. 2 B). RPA reference vessels diameter distally
was maximal 4.7 mm. An antegrade venous approach was used to place a 0.0014 inch
guidewire into the right lower lobe PA. A Cook ﬂexor 4 Fr long sheath was used to
guide the Bentley BeGrow™ stent system into its ﬁnal position. Stent implantation was
successful and uneventful. A remaining indentation at the site of stenosis (minimal
diameter 4.4 mm postintervention) was left for later redilation, as the intervention was
performed across fresh surgical suture lines. Postinterventional angiography showed
successful stent expansion of the RPA (Fig. 2 F).
3. Discussion and conclusion
Usage and handling of this new, low-proﬁle stent system was easy
and resulted in successful stent expansion of the PAs in both reported
cases. In comparison to currently available coronary stent systems, the
BeGrow™ stent system offers new treatment options for transcatheter
stent implantations, as it has the potential for further redilations and
importantly controlled stent strut breakage. Currently available, small
and ﬂexible coronary stent systems used in newborns and infants
so far, are limited by their ﬁnal expansion diameter of approximately
6–7 mm diameter [5]. The potential for further stent redilations is an
important feature in both illustrated cases of infants with procedural
bodyweights of 3.2 kg and 3.5 kg, respectively.
In comparison to other commonly used stents in children with CHD,
as for example the Cook Formula stent [6] Palmaz stents [7] or the Bard
Valeo stent [8], the mentioned stents have limited expansion diameters
after redilations, need larger introducing sheaths or guide wires, have
limited radial strength after further redilations and lack the potential
for controlled stent strut breakage [6,8]. While other groups have
reported intentional uncontrolled stent breakage of common available
stents [9,10], this stent offers a new unique stent design with
predetermined stent strut breakage points, which makes its use in
newborns and infants with CHD lesions extremely attractive.
Impact on daily practise
The low-proﬁle BeGrow™ stent system offers new treatment
options for transcatheter stent implantations in newborns and infants.
In our ﬁrst experience, it can be effectively implanted. Longer follow-
up will evaluate multiple, stepwise redilations and controlled stent
strut breakage, which have the potential to accommodate for somatic
vessel growth and/or subsequent implantation of larger stents.
Appendix A. Supplementary data
Supplementary data to this article can be found online at https://doi.
org/10.1016/j.ijcard.2018.11.029.
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